SUPERPIME

Cefepime

Anti-infective

 
 
 
 
 


Indication

 Moderate to severe Pneumonia caused by Pseudomonas aeruginosa, Klebsiella pneumoniae, Streptococcus pneumoniae and other gram negative organisms. Empiric monotherapy for Febrile Neutropenia. Uncomplicated and complicated urinary tract infections, including pyelonephritis caused by typical urinary tract pathogens (E. coli, Klebsiella pneumoniae, Proteus mirabilis). Uncomplicated skin and skin structure infections caused by Staphylococcus aureus or Streptococcus pyogenes. It is also used for Intra-abdominal infections with metronidzole and also active against methicillin-susceptible staphylococci and many other gram-negative bacilli.


Dosage and Administration

Usual recommended dose is as follows:

Adults: 500 mg- 2 g every 12 hourly for 7-10 days.

For febrile neutropenia: 2 g every 8 hourly for 7-10 days.

Pediatrics (2 months & above): 50 mg/kg every 12 hourly for 7-10 days.

For febrile neutropenia: 50 mg/kg every 8 hourly for 7-10 days. 

OR, AS DIRECTED BY PHYSICIAN.


Composition

Superpime 500 mg IM/ IVEach vial contains sterile Cefepime Hydrochloride USP powder with Arginine equivalent to Cefepime 500 mg.

Superpime 1 g IM/ IVEach vial contains sterile Cefepime Hydrochloride USP powder with Arginine equivalent to Cefepime 1 g.


 
 

Other Anti-infective Products